Search results
Results from the WOW.Com Content Network
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Inovio Pharmaceuticals wasn’t one of them. The 10 stocks that ...
Investors have cheered the progress of its COVID-19 DNA vaccine candidate INO-4800 by sending shares on a mightily impressive run – the stock is up by 505% since the turn of the year (even after ...
It’s been a thrilling year of ups and downs for Inovio (NASDAQ:INO). INO stock rocketed as much as 1,000% earlier this year following news that Inovio had a leading candidate in the race for a ...
A Q2 update about the progress of a late-stage clinical study provides a nice boost to the clinical-stage biotech stock. Why Inovio Pharmaceuticals, Inc. Stock Is Jumping 12.4% Today Skip to main ...
This week, one of the key players in the COVID-19 vaccine race took a leap forward.On Tuesday, Inovio Pharmaceuticals (INO) announced that Thermo Fisher Scientific had signed a letter of intent to ...
In May 2021, Inovio announced the results of preclinical studies on a "pan-SARS-CoV-2" DNA vaccine (INO-4802) and plans to initiate phase I/II studies. The vaccine incorporates common overlapping mutations from several SARS-COV-2 variants of concern isolated from several different countries including Brazil and India.
If there's one thing that traders have learned about Inovio Pharmaceuticals (NASDAQ:INO) stock, it's that half a year can make a huge difference. Biotechnology stocks can be fast movers, sure, but ...
On 26 August 2021 Inovio's global Phase 3 efficacy trial receives authorization to proceed from Brazil. [10] On 26 October 2021 The World Health Organization launched a Global Covid-19 Trial termed as the Solidarity Trial Vaccines. Inovio INO-4800 was chosen as the first DNA Vaccine to be introduced in the largest vaccine trial in history.